News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Apixaban recommended for thromboprophylaxis in ovarian cancer patients on chemo
09 Sep 2025
byAudrey Abella
Data presented at ESMO Gyn 2025 support apixaban as a prophylactic agent for venous thromboembolism (VTE) in women with epithelial ovarian cancer who are undergoing neoadjuvant chemotherapy consisting of carboplatin and paclitaxel.
Apixaban recommended for thromboprophylaxis in ovarian cancer patients on chemo
09 Sep 2025
Second cancers may develop in women with early invasive breast cancer
08 Sep 2025
byStephen Padilla
Women treated for early invasive breast cancer have a slightly higher risk of a second primary cancer than those in the general population, reveals a study. Such risk is greater among younger women.
Second cancers may develop in women with early invasive breast cancer
08 Sep 2025
Transforming lymphoma management through collaborative care and strong support
08 Sep 2025
bySaras Ramiya, Senior Editor, MPF
Lymphocytes are an important subset of white blood cells which have a central role in the immune system’s defence against pathogens such as bacteria and viruses. A type of blood cancer, lymphoma develops when a mutation in normal lymphocytes transforms them into abnormal, cancerous cells.






